Literature DB >> 9672913

Treatment of articular cartilage defects in athletes: an analysis of functional outcome and lesion appearance.

F T Blevins1, J R Steadman, J J Rodrigo, J Silliman.   

Abstract

This article characterizes chondral injuries and reviews the results of microfracture treatment in high-level competitive and recreational athletes. Thirty-eight high-level and 140 recreational athletes completed functional questionnaires preoperatively and yearly postoperatively, recording symptoms, function, and activity level. Second-look arthroscopy tapes were available in 26 high-level and 54 recreational athletes. The mean follow-up for the high-level athletes was 3.7 +/- 1.4 years. Chondral defects averaged 223 +/- 180 mm2. Lesion size and follow-up were not significantly different in the recreational group. Functional questionnaire responses demonstrated significant improvements from the time of microfracture to final follow-up. Improvement in function and symptoms was similar for the competitive and recreational athletes.

Entities:  

Mesh:

Year:  1998        PMID: 9672913     DOI: 10.3928/0147-7447-19980701-05

Source DB:  PubMed          Journal:  Orthopedics        ISSN: 0147-7447            Impact factor:   1.390


  48 in total

1.  Arthroscopy and microfracture technique in the treatment of osteochondritis dissecans of the humeral capitellum: report of three adolescent gymnasts.

Authors:  Ivan Bojanić; Alan Ivković; Igor Borić
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2005-10-11       Impact factor: 4.342

2.  Fresh osteochondral allografts for posttraumatic knee defects: long-term followup.

Authors:  A E Gross; W Kim; F Las Heras; D Backstein; O Safir; K P H Pritzker
Journal:  Clin Orthop Relat Res       Date:  2008-05-09       Impact factor: 4.176

3.  Hydrogels for osteochondral repair based on photocrosslinkable carbamate dendrimers.

Authors:  Lovorka Degoricija; Prashant N Bansal; Serge H M Söntjens; Neel S Joshi; Masaya Takahashi; Brian Snyder; Mark W Grinstaff
Journal:  Biomacromolecules       Date:  2008-09-19       Impact factor: 6.988

4.  "Long-term results after microfracture treatment for full-thickness knee chondral lesions in athletes" Knee Surg Sports Traumatol Arthrosc (2014) 22:1986-1996 DOI 10.1007/s00167-013-2676-8.

Authors:  Nael Hawi; Carl Haasper
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2015-02-11       Impact factor: 4.342

5.  Microfracture versus microfracture and platelet-rich plasma: arthroscopic treatment of knee chondral lesions. A two-year follow-up study.

Authors:  Annalisa Mancò; Remo Goderecci; Anna Rughetti; Silvana DE Giorgi; Stefano Necozione; Alfredo Bernardi; Vittorio Calvisi
Journal:  Joints       Date:  2016-09-21

Review 6.  2010 Nicolas Andry Award: Multipotent adult stem cells from adipose tissue for musculoskeletal tissue engineering.

Authors:  Farshid Guilak; Bradley T Estes; Brian O Diekman; Franklin T Moutos; Jeffrey M Gimble
Journal:  Clin Orthop Relat Res       Date:  2010-07-13       Impact factor: 4.176

7.  Microfracture for knee chondral defects: a survey of surgical practice among Canadian orthopedic surgeons.

Authors:  John Theodoropoulos; Tim Dwyer; Daniel Whelan; Paul Marks; Mark Hurtig; Pankaj Sharma
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2012-02-24       Impact factor: 4.342

Review 8.  Microfracture for the treatment of cartilage defects in the knee joint - A golden standard?

Authors:  Christoph Erggelet; P Vavken
Journal:  J Clin Orthop Trauma       Date:  2016-06-28

9.  Knee chondral lesions treated with autologous chondrocyte transplantation in a tridimensional matrix: clinical evaluation at 1-year follow-up.

Authors:  Félix Vilchez; Jorge Lara; Eduardo Alvarez-Lozano; Carlos E Cuervo; Oscar F Mendoza; Carlos A Acosta-Olivo
Journal:  J Orthop Traumatol       Date:  2009-11-20

10.  Evaluation of microfracture of traumatic chondral injuries to the knee in professional football and rugby players.

Authors:  Masoud Riyami; Christer Rolf
Journal:  J Orthop Surg Res       Date:  2009-05-07       Impact factor: 2.359

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.